J. Southwell

Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

L. Beletsky, C. Davis, Derek H Carr, 2015, American journal of public health.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

The burden of migraine on acute and emergency services in a London teaching hospital

S. Afridi, J. Southwell, 2021, Cephalalgia : an international journal of headache.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Emergency medical services naloxone access: a national systematic legal review.

Corey S. Davis, Alexander Y. Walley, A. Walley, 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Palliative care is not associated with decreased intensity of care: Results of a chart review from a large children's hospital

K. Pituch, J. Southwell, Jessica L. Spruit, 2021, Pediatric blood & cancer.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.